Expression of tumor necrosis factor-alpha in pulmonary fibrosis of rats after local blockage of renin-angiotensin-aldosterone system at different levels

Pingping He,Li JZ,Zhang SJ,Li JP,Long ZF,Zhang P

2007-01-01

Abstract:AIM: To observe the effects on the expression of tumor necrosis factor-α (TNF-α) in pulmonary fibrosis in rats after the blockage of renin-angiotensin-aldosterone system at different levels. METHODS: The experiment was carried out in the Clinical Institute of the First Affiliated Hospital of Nanhua University and the Laboratory of Histoembryology and Physiology in Nanhua University Medical College from August 2005 to August 2006. Fifty SD rats aged 6 weeks were randomized into five groups,with 10 rats in each. In the normal control group,the rats received intracheal instillation of normal saline,while other 40 rats received intratracheal instillation of 5 mg/kg bleomycin to induce the pulmonary fibrosis model. Next day,rats of three treatment groups were injected daily with captopril 60 mg/kg (captopril group),losartan 10 mg/kg (losartan group) and spironolactone 100 mg/kg (spironolactone group) by gastric canal. Control group and model group received normal saline everyday. Each group was sacrificed on the 28th day after intratracheal instillation. Histological changes of the lungs were evaluated by hematoxylin-eosin stain and Mallory stain. The expression of TNF-α was measured by immunhistochemical method with image analysis system. RESULTS: All 41 rats were involved in the result analysis.①The expression of TNF-α in lung tissues was increased in rats of model group compared with control group (166.82±4.14,61.44±1.94,P < 0.01),while these in captopril group,losartan group and spironolactone group were decreased compared with model group (107.50±4.60,113.64±8.47,118.00±7.14,P < 0.01). There were no significant differences among the three treatment groups.②The levels of lung fibrosis and alveolitis in rats of model group were significantly increased compared with control group (P < 0.01,P < 0.05),while these in captopril group,losartan group and spironolactone group were decreased (P < 0.01). The three treatment groups had no significant differences. CONCLUSION: Different sites of the renin-angiotensin-aldosterone system might play a role in the pathogenesis of pulmonary fibrosis by stimulating the expression of TNF-α in lung tissue. The blockage of the renin-angiotensin-aldosterone system at different sites could decrease the expression level of TNF-α and suppress the pathogenesis of pulmonary fibrosis.